No-reflow phenomenon coronary angiography: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{No-reflow phenomenon}} {{SI}} {{CMG}}; Jennifer Giuseffi, M.D.; David M. Leder, M.D.; {{AO}} ==Overview== ===Coronary Angiography=== ====Assessment of Epicardia...")
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{SI}}
{{SI}}


{{CMG}}; Jennifer Giuseffi, M.D.; David M. Leder, M.D.; {{AO}}
{{CMG}}; Jennifer Giuseffi, M.D.; David M. Leder, M.D.; {{AE}} {{AO}}, {{HP}}, {{Sapan}}


==Overview==
==Overview==
Line 24: Line 24:
* [[Digital subtraction angiography]] - This is a quantitative approach which estimates the rate of brightness and the rate of growth of the blush.  At the peak of the contrast intensity, an area of the myocardium is sampled to determine the increase in brightness in Gy/secs and the circumference of the brightness is measured by a handheld planimeter.  The number of frames required for the myocardium to reach peak brightness is converted into time by dividing the frame count by 30.
* [[Digital subtraction angiography]] - This is a quantitative approach which estimates the rate of brightness and the rate of growth of the blush.  At the peak of the contrast intensity, an area of the myocardium is sampled to determine the increase in brightness in Gy/secs and the circumference of the brightness is measured by a handheld planimeter.  The number of frames required for the myocardium to reach peak brightness is converted into time by dividing the frame count by 30.
* [[TIMI frame count (TFC)|Corrected TIMI frame count (CFTC)]] - This was designed to overcome the limitations of TFG as a more accurate method of estimating the coronary blood flow.
* [[TIMI frame count (TFC)|Corrected TIMI frame count (CFTC)]] - This was designed to overcome the limitations of TFG as a more accurate method of estimating the coronary blood flow.
==No-reflow Examples==
===[[No-reflow case 1|Case 1]]===


==References==
==References==

Latest revision as of 16:23, 20 September 2013

No-reflow phenomenon Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Electrocardiography

Coronary Angiography

Myocardial Contrast Echocardiography

Coronary Doppler Imaging

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

No-reflow phenomenon coronary angiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of No-reflow phenomenon coronary angiography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on No-reflow phenomenon coronary angiography

CDC onNo-reflow phenomenon coronary angiography

No-reflow phenomenon coronary angiography in the news

Blogs on No-reflow phenomenon coronary angiography

Directions to Hospitals Treating No-reflow phenomenon

Risk calculators and risk factors for No-reflow phenomenon coronary angiography

WikiDoc Resources for No-reflow phenomenon coronary angiography

Articles

Most recent articles on No-reflow phenomenon coronary angiography

Most cited articles on No-reflow phenomenon coronary angiography

Review articles on No-reflow phenomenon coronary angiography

Articles on No-reflow phenomenon coronary angiography in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on No-reflow phenomenon coronary angiography

Images of No-reflow phenomenon coronary angiography

Photos of No-reflow phenomenon coronary angiography

Podcasts & MP3s on No-reflow phenomenon coronary angiography

Videos on No-reflow phenomenon coronary angiography

Evidence Based Medicine

Cochrane Collaboration on No-reflow phenomenon coronary angiography

Bandolier on No-reflow phenomenon coronary angiography

TRIP on No-reflow phenomenon coronary angiography

Clinical Trials

Ongoing Trials on No-reflow phenomenon coronary angiography at Clinical Trials.gov

Trial results on No-reflow phenomenon coronary angiography

Clinical Trials on No-reflow phenomenon coronary angiography at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on No-reflow phenomenon coronary angiography

NICE Guidance on No-reflow phenomenon coronary angiography

NHS PRODIGY Guidance

FDA on No-reflow phenomenon coronary angiography

CDC on No-reflow phenomenon coronary angiography

Books

Books on No-reflow phenomenon coronary angiography

News

No-reflow phenomenon coronary angiography in the news

Be alerted to news on No-reflow phenomenon coronary angiography

News trends on No-reflow phenomenon coronary angiography

Commentary

Blogs on No-reflow phenomenon coronary angiography

Definitions

Definitions of No-reflow phenomenon coronary angiography

Patient Resources / Community

Patient resources on No-reflow phenomenon coronary angiography

Discussion groups on No-reflow phenomenon coronary angiography

Patient Handouts on No-reflow phenomenon coronary angiography

Directions to Hospitals Treating No-reflow phenomenon coronary angiography

Risk calculators and risk factors for No-reflow phenomenon coronary angiography

Healthcare Provider Resources

Symptoms of No-reflow phenomenon coronary angiography

Causes & Risk Factors for No-reflow phenomenon coronary angiography

Diagnostic studies for No-reflow phenomenon coronary angiography

Treatment of No-reflow phenomenon coronary angiography

Continuing Medical Education (CME)

CME Programs on No-reflow phenomenon coronary angiography

International

No-reflow phenomenon coronary angiography en Espanol

No-reflow phenomenon coronary angiography en Francais

Business

No-reflow phenomenon coronary angiography in the Marketplace

Patents on No-reflow phenomenon coronary angiography

Experimental / Informatics

List of terms related to No-reflow phenomenon coronary angiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jennifer Giuseffi, M.D.; David M. Leder, M.D.; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2], Hardik Patel, M.D., Sapan Patel M.B.B.S

Overview

Coronary Angiography

Assessment of Epicardial Blood Flow

This involves the use of Thrombolysis in Myocardial Infarction (TIMI) blood flow grades (TFG) to evaluate epicardial coronary blood flow in acute coronary syndromes. This method measures the coronary artery clearance of the injected radiographic dye. It is graded from 0 to 3. Click here to view the grading system. Although TFG has been associated with clinical outcomes in the past,[1] its use has been limited by many confounding variables such as the location of infarct. For example, the majority of TFG 3 are located in the right coronary artery, while the majority of TFG 2 are observed in the left anterior descending artery.[1] A more accurate technique to evaluate epicardial coronary blood flow is by using the number of angiographic frames required for a dye to reach a specified distal segment in the coronary artery, this was referred to as the TIMI frame count (TFC) by Gibson et al in 1999. Although this method was associated with improved clinical outcomes, however, it is now understood that restoration of epicardial blood flow does not necessarily improve perfusion at the tissue level or microvascular perfusion.[2]

TIMI flow grade 0 in RCA TIMI flow grade 0 in RCA: Outlined in blue in the second image is the flow of the dye which completely stops at the level of the stenosis; outlined with a yellow dashed line is the pathway that the dye would have filled in case the stenosis was absent.


Shown above is an animated image and a static image depicting TIMI flow grade 0 in the RCA. Outlined in blue in the second image is the flow of the dye which completely stops at the level of the stenosis. Outlined with a yellow dashed line is the pathway that the dye would have filled in case the stenosis was absent.

Assessment of Myocardial Perfusion

Perfusion of the myocardium has been shown to be an independent predictor of outcome.[3] This can be assessed directly by using myocardial blush grade (MBG), TIMI Myocardial Perfusion Grade (TMPG), coronary clearance frame count or digital subtraction angiography or can be assessed indirectly by using the corrected TIMI frame counts.

  • TMPG focuses on the rate of clearance of the contrast opacity as well as the degree of intensity of the contrast opacity in the infarcted area when compared with the non-infarcted areas, while MBG focuses on the latter. Both of these methods are subjected, therefore, they are affected by observer bias.
  • Coronary clearance frame count (CCFC) - This is a quantitative method designed to remove the observer bias associated with the prior methods. In order to calculate the CCFC, Frame 'O' represents the first frame in which the contrast medium is seen to be cleared from the ostium of the infarcted artery and the 'last frame' represents the point when the contrast begins to be cleared from the standardized distal landmark proposed by the TIMI Group. The difference between these two values of the frame counts is defined as the CCFC. The CCFC has been shown to correlate with both the TMPG and the MBG.[4]
  • Digital subtraction angiography - This is a quantitative approach which estimates the rate of brightness and the rate of growth of the blush. At the peak of the contrast intensity, an area of the myocardium is sampled to determine the increase in brightness in Gy/secs and the circumference of the brightness is measured by a handheld planimeter. The number of frames required for the myocardium to reach peak brightness is converted into time by dividing the frame count by 30.
  • Corrected TIMI frame count (CFTC) - This was designed to overcome the limitations of TFG as a more accurate method of estimating the coronary blood flow.

No-reflow Examples

Case 1

References

  1. 1.0 1.1 Gibson, CM.; Cannon, CP.; Daley, WL.; Dodge, JT.; Alexander, B.; Marble, SJ.; McCabe, CH.; Raymond, L.; Fortin, T. (1996). "TIMI frame count: a quantitative method of assessing coronary artery flow". Circulation. 93 (5): 879–88. PMID 8598078. Unknown parameter |month= ignored (help)
  2. Ito, H.; Tomooka, T.; Sakai, N.; Yu, H.; Higashino, Y.; Fujii, K.; Masuyama, T.; Kitabatake, A.; Minamino, T. (1992). "Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction". Circulation. 85 (5): 1699–705. PMID 1572028. Unknown parameter |month= ignored (help)
  3. Gibson, CM.; Cannon, CP.; Murphy, SA.; Marble, SJ.; Barron, HV.; Braunwald, E. (2002). "Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction". Circulation. 105 (16): 1909–13. PMID 11997276. Unknown parameter |month= ignored (help)
  4. Perez de Prado, A.; Fernández-Vázquez, F.; Cuellas-Ramón, JC.; Iglesias-Garriz, I. (2005). "Coronary clearance frame count: a new index of microvascular perfusion". J Thromb Thrombolysis. 19 (2): 97–100. doi:10.1007/s11239-005-1379-5. PMID 16052299. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources